Gammaplex (intravenous normal human immunoglobulin) / Bio Products Lab  >>  Phase 3
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Gammaplex (intravenous normal human immunoglobulin) / Bio Products Lab
NCT00278954: Efficacy, Safety and Pharmacokinetics of Gammaplex in Primary Immunodeficiency Diseases.

Completed
3
50
US
Gammaplex (Intravenous immunoglobulin)
Bio Products Laboratory
Primary Immunodeficiency, Common Variable Hypogammaglobulinemia, X-linked Hypogammaglobulinemia, Hypogammaglobulinemia, Immunodeficiency With Hyper-IgM, Wiskott-Aldrich Syndrome
11/07
11/07
NCT00504075 / 2011-005586-21: A Study to Find How Safe and Effective GAMMAPLEX® is in Subjects With Chronic Idiopathic Thrombocytopenic Purpura (ITP)

Completed
3
35
US, RoW
Gammaplex, intravenous immunoglobulin, Gammaplex
Bio Products Laboratory
Chronic Idiopathic Thrombocytopenic Purpura
08/11
08/11
GMX07, NCT01963143 / 2013-002290-21: Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases

Completed
3
48
US, Europe
Gammaplex (5%), Gammaplex 10
Bio Products Laboratory
Primary Immune Deficiency Disorders, Common Variable Immunodeficiency, X-linked Agammaglobulinaemia, Hyper-IgM Syndrome
01/16
05/16
NCT01884311: Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases

Completed
3
38
US
Subgam, Subgam-VF
Bio Products Laboratory
Primary Immune Deficiency Disorders, Common Variable Immunodeficiency, X-linked Agammaglobulinaemia, Hyperimmunoglobulin M Syndrome
05/17
05/17

Download Options